Urs Meyer is Professor (active emeritus) at the Biozentrum of the University of Basel. He holds a MD degree with additional laboratory training in bio- chemistry and metabolic diseases and specialised in internal medicine. In 1975 he became professor in Clinical Pharmacology and joined the Biozentrum in 1983 as Professor of Pharmacology. Urs research has focused on “pharmacological individuality” or person-to-person variation of drug response throughout his career. His laboratory is best known for the discovery of the molecular mechanisms of several common genetic polymorphisms of drug disposition. His team identified the genes and mutations in these genes causing variation in drug response and developed the first pharmacogenetic DNA tests.

Thomas Szucs is Professor of Pharmaceutical Medicine and Director of ECPM at the University of Basel, and Professor and part-time lecturer for Medical Economics at the University of Zurich. Professor Szucs’ former appointments include head of research and founder of the Center of Pharmacoeconomics of the University of Milan, head of the working group for Clinical Economics at the University of Munich, and head of the Department of Health Economics at F. Hoffmann-La Roche Ltd. in Basel. He holds a medical degree from the University of Basel, a MBA from the University of St Gallen, a Master of Public Health degree from Harvard University, and is board certified in Pharmaceutical Medicine as well as in Prevention and Public Health.